Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: A cohort study in primary care

BMJ Open

Volumn 3, Issue 7, 2013, Pages

  De Jong, Hilda J I ^a   Korevaar, Joke C ^a   Van Dijk, Liset ^a   Voogd, Eef ^a   Van Dijk, Christel E ^a   Van Oijen, Martijn G H ^b,c  

^a NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; COHORT ANALYSIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TREATMENT DURATION;

EID: 84883311080     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003044     Document Type: Article

References (31)

1. World Health Organisation. Global atlas on cardiovascular disease prevention and control. 10-1-2012.
2. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324: 71-86.
3. Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373: 1849-60.
4. Chen ZM, Sandercock P, Pan HC, et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke 2000;31: 1240-9. (Pubitemid 30351240)
5. Wolff T, Miller T, Ko S. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009;150: 405-10.
6. McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med 2006;119: 624-38. (Pubitemid 44128438)
7. Yeomans ND, Lanas AI, Talley NJ, et al. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther 2005;22: 795-801. (Pubitemid 41564359)
8. Hsiao FY, Tsai YW, Huang WF, et al. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. Clin Ther 2009;31: 2038-47.
9. Ng FH, Wong SY, Lam KF, et al. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. Gastroenterology 2010;138: 82-8.
10. Scheiman JM, Devereaux PJ, Herlitz J, et al. Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON). Heart 2011;97: 797-802.
11. Yeomans ND. Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid. Expert Rev Gastroenterol Hepatol 2011;5: 447-55.
12. Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2008;118: 1894-909.
13. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32: 2999-3054.
14. Ministerie van Volksgezondheid WeS. Een voorstel van de Expertgroep Medicatieveiligheid met betrekking tot concrete interventies die de extramurale medicatieveiligheid op korte termijn kunnen verbeteren. HARM-WRESTLING. 2009. Den Haag, The Netherlands.
15. NICE. Acute upper gastrointestinal bleedings: management. NICE clinical guideline 141. 2012.
16. Abraham NS, Hlatky MA, Antman EM, et al. ACCF/ACG/AHA 2010 Expert Consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ ACG/AHA 2008 Expert Consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2010;56: 2051-66.
17. Valkhoff VE, van Soest EM, Sturkenboom MC, et al. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs). Aliment Pharmacol Ther 2010;31: 1218-28.
18. Hartnell NR, Flanagan PS, Mackinnon NJ, et al. Use of gastrointestinal preventive therapy among elderly persons receiving antiarthritic agents in Nova Scotia, Canada. Am J Geriatr Pharmacother 2004;2: 171-80. (Pubitemid 39618442)
19. Sturkenboom MC, Burke TA, Dieleman JP, et al. Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford) 2003;42(Suppl 3):iii23-31. (Pubitemid 37407011)
20. Lanas A, Plazas MA, Gimeno E, et al. Gastroprotection in NSAID and low-dose aspirin users: a cross-sectional study in primary care. Gastroenterol Hepatol 2012;35: 1-7.
21. Bianco MA, Rotondano G, Buri L, et al. Gastro-protective strategies in primary care in Italy: the "Gas.Pro." survey. Dig Liver Dis 2010;42: 359-64.
22. Stirbu-Wagner I, Dorsman SA, Visscher S, et al. Netherlands Information Network of General Practice (LINH). Utrecht/Nijmegen, NIVEL/IQ, 2012.
23. Schellevis FG, Westert GP, De Bakker DH. [The actual role of general practice in the dutch health-care system. Results of the second dutch national survey of general practice]. Med Klin (Munich) 2005;100: 656-61. (Pubitemid 41442602)
24. World Health Organisation. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methodology - Nordic Council on Medicines, 1999.
25. Lamberts H, Wood M. ICPC. International classification of primary care. Oxford: Oxford University Press, 1987.
26. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000;321: 1183-7.
27. Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007;102: 2047-56. (Pubitemid 47301504)
28. Laheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292: 1955-60. (Pubitemid 39411203)
29. Yang YX, Lewis JD, Epstein S, et al. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006;296: 2947-53. (Pubitemid 46021498)
30. Richtlijn overdracht van medicatie gegevens in de keten. 2008. VWS and IGZ.
31. Kvamme OJ, Olesen F, Samuelson M. Improving the interface between primary and secondary care: a statement from the European Working Party on Quality in Family Practice (EQuiP). Qual Health Care 2001;10: 33-9.